,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destinybreast04', 'destiny,breast,4', 'breast']
the #oncoalerttoptweet day 3 #asco22 tweet #destinybreast04 trial at #asco22 plenary session one of the most important moment in the history of this disease #breastcancer best, 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??